Journey Medical Corporation Common Stock

DERMNASDAQUSD
7.75 USD
0.26 (3.47%)AT CLOSE (11:59 AM EDT)
7.68
0.08 (0.97%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
7.68
0.08 (0.97%)
🔴Market: CLOSED

Journey Medical Corporation Common Stock (DERM) is currently trading at $7.75. DERM shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place DERM at a fair price relative to peers.

Technical & fundamental data as of Aug 21, 2026.

Open?$7.56
High?$8.10
Low?$7.56
Prev. Close?$7.49
Volume?264.0K
Avg. Volume?208.4K
VWAP?$7.80
Rel. Volume?1.27x
Bid / Ask
Bid?$7.55 × 4.0K
Ask?$7.80 × 100
Spread?$0.25
Midpoint?$7.68
Valuation & Ratios
Market Cap?218.7M
Shares Out?22.2M
Float?12.0M
Float %?55.9%
P/E Ratio?N/A
P/B Ratio?6.81
EPS?-$0.22
Dividend?0.00%
Ex-Dividend?N/A
RelatedFBIO
News
Profile
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Employees
58
Market Cap
218.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-11-12
Address
9237 E VIA DE VENTURA BLVD., SUITE 105
SCOTTSDALE, AZ 85258
Phone: 480-434-6670
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
18
Momentum?
65
Short Sent.?
24
Piotroski F-Score?3/9Weak
Altman Z-Score?1.41Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?23.87%Squeeze Risk
Short Interest?2.9M
Days to Cover?20.5
Free Float12.0M
Avg Daily Volume140.1K
Settlement Date2026-07-31
Financial Health
Current Ratio?1.59Adequate
Quick Ratio?1.41Adequate
Cash Ratio?0.56Adequate
Debt/Equity?0.81Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A
P/B?
Peers
50
S&P
27
6.81FAIR
P/S?
Peers
50
S&P
47
3.27FAIR
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
-2,959.2CHEAP
EV/Sales?
S&P
57
3.27FAIR
Returns & Efficiency
ROE?
Peers
50
S&P
8
-19.0%WEAK
ROA?
Peers
50
S&P
3
-6.2%WEAK
Cash Flow & Enterprise
FCF?$-7492000
Enterprise Value?$219.0M
Fundamentals ratios updated end of day